翰宇药业参股碳云智肽 深化AI多肽药物开发与产业化协同

Core Viewpoint - Hanyu Pharmaceutical has entered into a strategic investment cooperation with Shenzhen Carbon Cloud Smart Peptide Pharmaceutical Technology Co., Ltd, marking a shift from prior R&D collaboration to deeper capital binding and industrial synergy [1] Group 1 - Hanyu Pharmaceutical will invest 10 million yuan in cash to subscribe to the newly registered capital of Carbon Cloud Smart Peptide [1] - After the capital increase, Hanyu Pharmaceutical will hold a 0.6623% equity stake in Carbon Cloud Smart Peptide [1] - This partnership signifies a transition to a more integrated collaboration between the two companies [1]